| Mr Paul M Kulp, APRN/PMH | |
|
8600 Old Georgetown Rd, Bethesda, MD 20814-1422 | |
| (240) 242-7769 | |
| Not Available |
| Full Name | Mr Paul M Kulp |
|---|---|
| Gender | Male |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health |
| Location | 8600 Old Georgetown Rd, Bethesda, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083936322 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0808X | Clinical Nurse Specialist - Psychiatric/mental Health | R118086 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Paul M Kulp, APRN/PMH 8600 Old Georgetown Rd, Bethesda, MD 20814-1422 Ph: (301) 896-2218 | Mr Paul M Kulp, APRN/PMH 8600 Old Georgetown Rd, Bethesda, MD 20814-1422 Ph: (240) 242-7769 |
News Archive
ZOLL Medical Corporation, a manufacturer of resuscitation devices and software solutions, today announced that revenues for the third quarter of fiscal 2010 increased 17% to $111.3 million, compared to revenues in the third quarter of last year of $95.1 million. The third quarter 2010 results included approximately $5.0 million of revenue from the Temperature Management business, compared to $1.9 million of revenue in the third quarter of last year.
Understanding how and why we evolved such large brains is one of the most puzzling issues in the study of human evolution. It is widely accepted that brain size increase is partly linked to changes in diet over the last 3 million years, and increases in meat consumption and the development of cooking have received particular attention from the scientific community.
Flavor, safety and family attitude toward vaping are among the greatest factors influencing teenage perception of e-cigarettes, new University at Buffalo research finds.
OptiNose Inc. announces the filing of an Investigational New Drug (IND) with the U.S. Food and Drug Administration (FDA) in December, 2011. The FDA has completed its review and has notified OptiNose that the studies under this IND may proceed. The Company will initiate Phase III trials in adults with acute migraine with or without aura utilizing its novel intranasal technology.
A recent team grant by the Canadian Institute for Health Research is providing an innovative approach to researching patient safety for those who provide and receive spinal-manipulative therapy. The $2-million grant over five years brings together health researchers from across Canada and will involve input from four regulatory colleges in Alberta.
› Verified 7 days ago
Dr. Jesse Yamil Rivera-rosario, DNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 8901 Rockville Pike, Bethesda, MD 20889 Phone: 301-319-2577 | |
Albert R Knight, RN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 4301 Jones Bridge Rd, Bethesda, MD 20814 Phone: 409-781-6154 | |
Alainna Crotty, APRN, AGCNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 8901 Rockville Pike, Bethesda, MD 20889 Phone: 717-395-5178 | |
Myra Woolery, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 10 Center Dr Bldg 10, 2b-01, Bethesda, MD 20892 Phone: 301-978-6428 | |
Ms. Lauren Quirao, RN, BSN, CNOR, USAF Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: Walter Reed Naval Military Medical Center, Bethesda, MD 20889 Phone: 210-709-1284 | |
Maria Dias Raynal, APRN MS BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 5805 Springfield Dr, Bethesda, MD 20816 Phone: 301-320-2656 |